On 14th of May, AmCham Healthcare Committee meeting took place over Zoom, bringing members together to discuss planning for the upcoming Healthcare Forum 2026 and key healthcare policy priorities in Estonia.
The group agreed to focus the forum on “access to innovation”, with discussion also including the implications of the U.S. Most Favored Nation (MFN) medicines pricing policy and its potential impact on Europe and access to medicines.
We were also pleased to welcome new members from Novo Nordisk, Tamro Baltics, and Unitas Pharma.
A task force has been formed to further develop the forum concept ahead of the summer period.
Thank you to all participants for the productive and insightful discussion.
